Can-Fite BioPharma (CANF) Exchange Rate Effect (2013)
Can-Fite BioPharma (CANF) posted Exchange Rate Effect of -$40000.0 for Q3 2013.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Exchange Rate Effect (2013) Analysis & Trends
Can-Fite BioPharma (CANF) has 1 years of Exchange Rate Effect data on file, last reported at -$40000.0 in Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | - |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - | - |